Literature DB >> 25617817

Atypical presentations of bullous pemphigoid: Clinical and immunopathological aspects.

Emanuele Cozzani1, Giulia Gasparini2, Martina Burlando3, Francesco Drago4, Aurora Parodi5.   

Abstract

Bullous pemphigoid may occur in extremely variegated manners, misleading even experienced dermatologists. Indeed the type and/or distribution of lesions may be unusual. Furthermore, there may be an atypical demographic profile of patients, a different clinical course and a different responsiveness to therapy. Up to 20% of the cases the onset is characterized by a non-bullous phase, lasting weeks, months or in particular cases remaining the only manifestation of the disease. During this early phase lesions are generally pruritic erythematous, eczematous or urticarial; however, lesions may also resemble polycyclic, targetoid, nodular or lichenoid lesions. These atypical lesions may also coexist with typical bullae. Other atypical presentations include a vesicular eruption and an erythroderma. Manifestations in children differ from adult forms, presenting an exclusive genital involvement in 50% of cases or a preponderant involvement of the face, the palms and the soles. Rarely bullous pemphigoid is confined to certain body areas, due to particular triggering factors or to a lower disease activity. Therefore, the need to formulate universally recognized diagnostic criteria is increasingly evident, especially for atypical bullous pemphigoid. Direct immunofluorescence of perilesional skin and detection of circulating autoantibodies are mandatory in the diagnosis, especially when the clinical presentation is doubtful.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atypical presentation; Autoimmune blistering diseases; Bullous pemphigoid; Clinical variants; Diagnosis; Diagnostic criteria

Mesh:

Substances:

Year:  2015        PMID: 25617817     DOI: 10.1016/j.autrev.2015.01.006

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  18 in total

Review 1.  Thyroid diseases and skin autoimmunity.

Authors:  Enke Baldini; Teresa Odorisio; Chiara Tuccilli; Severino Persechino; Salvatore Sorrenti; Antonio Catania; Daniele Pironi; Giovanni Carbotta; Laura Giacomelli; Stefano Arcieri; Massimo Vergine; Massimo Monti; Salvatore Ulisse
Journal:  Rev Endocr Metab Disord       Date:  2018-12       Impact factor: 6.514

2.  Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic Pattern.

Authors:  Genevieve J Kaunitz; Manisha Loss; Hira Rizvi; Sowmya Ravi; Jonathan D Cuda; Karen B Bleich; Jessica Esandrio; Inbal Sander; Dung T Le; Luis A Diaz; Julie R Brahmer; Charles G Drake; Travis J Hollmann; Mario E Lacouture; Matthew D Hellmann; Evan J Lipson; Janis M Taube
Journal:  Am J Surg Pathol       Date:  2017-10       Impact factor: 6.394

Review 3.  Autoimmunity in 2015.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

Review 4.  Bullous Pemphigoid Associated with Anti-programmed Cell Death Protein 1 and Anti-programmed Cell Death Ligand 1 Therapy: A Review of the Literature.

Authors:  Aikaterini Tsiogka; Johann W Bauer; Aikaterini Patsatsi
Journal:  Acta Derm Venereol       Date:  2021-01-20       Impact factor: 3.875

5.  Seborrheic pemphigoid.

Authors:  Lucia Lourdes O Castro-Forés; Jamaine Melisse L Cruz; Maria Jasmin J Jamora; Katrina M Canlas-Estrella
Journal:  JAAD Case Rep       Date:  2016-02-27

Review 6.  BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.

Authors:  Yale Liu; Liang Li; Yumin Xia
Journal:  Front Immunol       Date:  2017-12-08       Impact factor: 7.561

7.  A Case of Bullous Pemphigoid: A Prevalent and Potentially Fatal Condition.

Authors:  Jorge Parellada; Yanetsy Olivera Arencibia; Harold Watson; Nicole Parellada; Lara E Saikaly; Sami K Saikaly
Journal:  Cureus       Date:  2018-04-25

Review 8.  Bullous pemphigoid.

Authors:  Denise Miyamoto; Claudia Giuli Santi; Valéria Aoki; Celina Wakisaka Maruta
Journal:  An Bras Dermatol       Date:  2019-05-09       Impact factor: 1.896

9.  An unusual case of bullous haemorrhagic vasculitis in a COVID-19 patient.

Authors:  S Negrini; A Guadagno; M Greco; A Parodi; M Burlando
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-06       Impact factor: 9.228

Review 10.  A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management.

Authors:  Adriana T Lopez; Larisa Geskin
Journal:  Oncologist       Date:  2018-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.